- Netflix: The Biggest Empty Promise Since Enron?
- Why Car Prices Vary From City To City
- Big Bank Phobia: Not Too Big to Fail
- Apple Should Still Fire Tim Cook
- Expect Your Health Care in Retirement to Hit $200,000
Morning Briefing: 10 Things You Should Know
Stock futures are flat; Cisco's earnings and revenue top forecasts; Wal-Mart's profit misses Wall Street estimates; Novartis eyes Actavis.
05/16/13 - 07:33 AM EDT
10 ASCO '13 Abstracts You Can Read Right Now
Get a head start on searching through ASCO abstracts with these 10 summaries.
05/15/13 - 06:00 PM EDT
Aveo Screwed Up but Its Kidney Cancer Drug Is Real
At some point, investors will give Aveo credit for tivozanib, says David Sobek.
05/15/13 - 09:24 AM EDT
Synta Is Run-Up to ASCO Lung Cancer Data
The market overreacted to the resignation of Synta's R&D chief.
05/14/13 - 10:16 AM EDT
TheStreet Ratings Top 10 Rating Changes
TheStreet Ratings released rating changes on 77 U.S. common stocks for week ending May 13, 2013. 45 stocks were upgraded and 32 stocks were downgraded by our stock model.
05/13/13 - 01:21 PM EDT
Video
Quintiles IPO Trades Higher
Quintiles Transnational prices its IPo at the high end of the range and moves higher in trading. CEO Tom Pike sees more growth ahead.
05/13/13 - 10:47 AM EDT
Morning Briefing: 10 Things You Should Know
U.S. stock futures point lower ahead of a retail sales report; Elan and Theravance in a $1 billion royalty agreement; Post Holdings and Take-Two report earnings.
05/13/13 - 07:27 AM EDT
SEC Is Investigating Spectrum Pharma
- Tickers in this article:
- SPPI
Regulators have issued a subpoena to Spectrum for information related to the steep cut in Fusilev sales in 2013.
05/13/13 - 07:19 AM EDT
The Deal: Bain, TPG Get Windfall With Quintiles IPO
- Tickers in this article:
- Q
Quintiles raises $947 million for investors including Bain and TPG Group as the research services company goes public.
05/10/13 - 11:51 AM EDT
Repros Patent Problems Began When Harry Met Joe
- Tickers in this article:
- RPRX
A New York fertility doctor accuses Repros CEO of stealing the idea for a new oral testosterone therapy.
05/09/13 - 08:00 AM EDT
Happy Day for Arena Bulls, Bears as Belviq Launch Finally Arrives
DEA finalizes Belviq abuse schedule, allowing the weight-loss pill launch in June.
05/07/13 - 11:53 AM EDT
Fire Aveo's CEO for Incompetence and Arrogance Rivaling ImClone's Sam Waksal
- Tickers in this article:
- AVEO
Heads need to roll at Aveo because of the FDA's thrashing of the company's kidney cancer drug.
05/06/13 - 12:26 PM EDT
